They noted the detailed SHARE recommendations for APS, and supported screening for antiphospholipid antibodies (lupus anticoagulant, anticardiolipin IgG and IgM and anti-β2-glycoprotein-I IgG and IgM) in all cSLE patients in accordance with the SHARE recommendations.32 Specifying a particular treatment approach for APS was deemed beyond the scope of these points-to-consider. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.